Drug intelligence / Profile preview

Octacod

Development stage: Unknown
Lead developer: Maks Drug
Modality: Small Molecules
Administration: Oral

Overview

Octacod is a nutritional supplement syrup developed and marketed by Maks Drug Limited in Bangladesh. It is a combination product containing eight essential vitamins (A, B1, B2, B6, C, D, E, and Nicotinamide) and cod liver oil. The formulation is primarily indicated for children to support the development and proper functioning of vital organs, prevent vitamin deficiencies, and restore vitality following illness. In adults, it is used for the prevention and management of chronic conditions such as cardiovascular disease, rheumatoid arthritis, COPD, and cancer. Additionally, it is indicated for pregnant and nursing mothers to support proper fetal and infant development.

Brand names: Octacod
Other names: Multivitamin + Cod Liver Oil

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Octacod.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octacod.

Explore the full profile